Cargando…
Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
PURPOSE: The majority of patients with high‐risk lower grade gliomas (LGG) are treated with single‐agent temozolomide (TMZ) and radiotherapy despite three randomized trials showing a striking overall survival benefit with adjuvant procarbazine, lomustine, and vincristine (PCV) chemotherapy and radio...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943166/ https://www.ncbi.nlm.nih.gov/pubmed/31701682 http://dx.doi.org/10.1002/cam4.2686 |